Cite
MLA Citation
Matthias Hepprich et al.. “Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial.” EClinicalMedicine, vol. 53, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100170503484.0x000005